Search research articles
Contact Us
Filters
Showing results (1-10 of 90) with videos related to
Page
of 9
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 28, 2015
How do we value a cure?
Don Husereau
Issues in Emerging Health Technologies
|
December 21, 2002
Imatinib mesylate for chronic myeloid leukemia: what do we really know?
Don Husereau
Applied Health Economics and Health Policy
|
November 23, 2019
Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists
Chiranjeev Sanyal, Don Husereau
Journal of Vascular Surgery
|
October 17, 2012
Trends in the utilization of endovascular therapy for elective and ruptured abdominal aortic aneurysm procedures in Canada
Prasad Jetty, Don Husereau
International Journal of Technology Assessment in Health Care
|
July 5, 2022
Redefining Health Technology Assessment: A Comment on "The New Definition of Health Technology Assessment: A Milestone in International Collaboration"
Anthony Culyer, Don Husereau
International Journal of Technology Assessment in Health Care
|
June 30, 2010
Priority setting for health technology assessment at CADTH
Don Husereau, Michel Boucher, Hussein Noorani
International Journal of Technology Assessment in Health Care
|
May 21, 2015
MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONS
Ilke Akpinar, Philip Jacobs, Don Husereau
International Journal of Technology Assessment in Health Care
|
June 13, 2014
Adaptive approaches to licensing, health technology assessment, and introduction of drugs and devices
Don Husereau, Chris Henshall, Jamil Jivraj
Applied Health Economics and Health Policy
|
February 8, 2018
Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching
Don Husereau, Brian Feagan, Carl Selya-Hammer
Plos One
|
June 14, 2018
Economic evaluations of eHealth technologies: A systematic review
Chiranjeev Sanyal, Paul Stolee, Don Juzwishin, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 90) with videos related to
Sort By:
Page
of 9
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 28, 2015
How do we value a cure?
Don Husereau
Issues in Emerging Health Technologies
|
December 21, 2002
Imatinib mesylate for chronic myeloid leukemia: what do we really know?
Don Husereau
Applied Health Economics and Health Policy
|
November 23, 2019
Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists
Chiranjeev Sanyal, Don Husereau
Journal of Vascular Surgery
|
October 17, 2012
Trends in the utilization of endovascular therapy for elective and ruptured abdominal aortic aneurysm procedures in Canada
Prasad Jetty, Don Husereau
International Journal of Technology Assessment in Health Care
|
July 5, 2022
Redefining Health Technology Assessment: A Comment on "The New Definition of Health Technology Assessment: A Milestone in International Collaboration"
Anthony Culyer, Don Husereau
International Journal of Technology Assessment in Health Care
|
June 30, 2010
Priority setting for health technology assessment at CADTH
Don Husereau, Michel Boucher, Hussein Noorani
International Journal of Technology Assessment in Health Care
|
May 21, 2015
MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONS
Ilke Akpinar, Philip Jacobs, Don Husereau
International Journal of Technology Assessment in Health Care
|
June 13, 2014
Adaptive approaches to licensing, health technology assessment, and introduction of drugs and devices
Don Husereau, Chris Henshall, Jamil Jivraj
Applied Health Economics and Health Policy
|
February 8, 2018
Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching
Don Husereau, Brian Feagan, Carl Selya-Hammer
Plos One
|
June 14, 2018
Economic evaluations of eHealth technologies: A systematic review
Chiranjeev Sanyal, Paul Stolee, Don Juzwishin, et al.
Page
of 9